| ¿µ¹® | aspirin | ÇÑ±Û | ¾Æ½ºÇǸ° |
|---|---|---|---|
| ¼³¸í | ½ºÅ×·ÎÀ̵尡 ¾Æ´Ñ Ç׿°Á¦ÀÇ ´ëÇ¥ÀûÀÎ ¾à¹°ÀÌ´Ù. Ç׿°Áõ, ÁøÅë, ÇØ¿ÀÇ 3°¡Áö ±â´ÉÀ» °¡Áø´Ù. ¾à¹°ÀÇ ±â´ÉÀº ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandin)ÀÇ Çü¼ºÀ» ¾ïÁ¦ÇÏ´Â °Í¿¡ ÀÇÇØ¼ ÀÌ·ç¾îÁø´Ù. ¿°ÁõÀ̶õ ¸ö¼Ó¿¡ µé¾î¿Â À̹°ÁúÀ» ó¸®ÇÏ´Â °úÁ¤À¸·Î ¿©±â¿¡´Â ¿©·¯ °¡Áö ¼¼Æ÷°¡ °ü¿©ÇÑ´Ù. ÇÁ·Î½ºÅ¸±Û¶õµò´Â ¿°ÁõÀÇ °úÁ¤¿¡¼ ¿©·¯ ¼¼Æ÷¸¦ ¸ðÀ¸´Â ±â´ÉÀ» ÇÏ´Â ¹°ÁúÀÌ´Ù. Áï ÇÁ·Î½ºÅ¸±Û¶õµòÀÇ Çü¼ºÀ» ¸·À¸¸é ¿°Áõ¿¡ °ü¿©ÇÏ´Â ¼¼Æ÷ÀÇ ÁýÇÕÀÌ ÀÌ·ç¾îÁöÁö ¾Ê¾Æ¼ ¿°ÁõÀÌ ÀϾÁö ¾Ê´Â´Ù. ÁöÇ÷ÀÇ °úÁ¤¿¡¼µµ ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ °ü¿©ÇÑ´Ù. Ãʱ⿡ Ç÷°üÀÌ ÅÍÁ® Çǰ¡ ³¯ ¶§¿¡ À̰ÍÀ» ¸·´Â °ÍÀº Ç÷¼ÒÆÇÀÌ´Ù. Áï Ç÷¼ÒÆÇÀÌ ¸ð¿© Ç÷°üÀÇ ¼Õ»óµÈ ºÎÀ§¸¦ Ʋ¾î¸·°Ô µÈ´Ù. ¿ª½Ã ÀÌ °úÁ¤¿¡¼µµ ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ Ç÷¼ÒÆÇÀ» ±× ºÎºÐ¿¡ ¸ðÀÌ°Ô ÇÏ´Â ¿ªÇÒÀ» ¼öÇàÇϹǷΠ¾Æ½ºÇǸ°À» ¸ÔÀ¸¸é ÁöÇ÷ÀÌ Àß µÇÁö ¾Ê´Â´Ù. ºÎÀÛ¿ëÀ¸·Î´Â ¼ÒÈÀå¾Ö, ÁöÇ÷ÀÇ Àå¾Ö, ¾ÆÁÖ µå¹°Áö¸¸ ¼Ò¾Æ¿¡¼ Ä¡¸íÀûÀÎ ¶óÀÌÁõÈıºÀÌ »ý±æ ¼ö°¡ ÀÖÀ¸¹Ç·Î ¼Ò¾Æ¿¡¼± Á¶½ÉÇØ¼ »ç¿ëÀ» ÇØ¾ß ÇÑ´Ù. ¾Æ¼¼»ì¸®½Ç»ê ÂüÁ¶. |
||
| ASA | acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes... |
|---|---|
| Tabs | tablets |
| AIA | Aspirin Induced Asthma |
| ASA, A.S.A. | Acetyl-Salicylic Acid(= Aspirin) |
| ACP | accessory conduction pathway; acid phosphatase; acyl carrier protein; American College of Pathologis... |
| ASA | Aspirin |
|---|---|
| AIA | Aspirin induced Asthma |
| ASP | aspirin |
| carisoprodol | <chemical> A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. Pharmacological action: muscle relaxants, central. Chemical name: Carbamic acid, (1-methylethyl)-, 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester (12 Dec 1998) |
|---|---|
| aluminum aspirin | An analgesic and antipyretic. Synonym: aluminum acetylsalicylate. (05 Mar 2000) |
| aspirin | <drug> Acetyl salicylate. An analgesic, antipyretic and antinflammatory drug. It is a potent cyclooxygenase inhibitor and blocks the formation of prostaglandins from arachidonic acid. (18 Nov 1997) |
| tablets | Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (12 Dec 1998) |
| tablets, enteric-coated | Tablets coated with material that delays release of the medication until after they leave the stomach. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|